Annals of hepatology (1117 documentos)


1.-
2.-
Cholangiohydatidosis: An infrequent cause of obstructive jaundice and acute cholangitis
Manterola, Carlos1; Otzen, Tamara2
1Universidad de La Frontera, Centro de Estudios Morfológicos y Quirúrgicos, Temuco, Cautín. Chile; 2Universidad Autónoma de Chile, Centro de Investigación Biomédica, Temuco, Cautín. Chile
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 436-441]

   
3.-
4.-
5.-
6.-
7.-
8.-
Liver Transplantation as Cure of Hepatocellular Carcinoma: It is not a Matter of Time, it is a Matter of Tumor Biology
Jochum, Christoph1; Canbay, Ali2
1University Duisburg-Essen, University Hospital, Essen, Nordrhein-Westfalen. Alemania; 2Otto von Guericke University, Department of Gastroenterology, Hepatology and Infectious Diseases, Magdeburgo, Sajonia-Anhalt. Alemania
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 326-327]

   
9.-
10.-
MRE in NAFLD: Promising but Further Validation is Required
Ryan, John D1; Tsochatzis, Emmanuel A1
1Royal Free Hospital, Sheila Sherlock Liver Unit, Londres. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 331-332]

   
11.-
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant
Yoshida, Eric M1; Kwo, Paul2; Agarwal, Kosh3; Duvoux, Christophe4; Durand, Francois5; Peck Radosavljevic, Markus6; Lilly, Leslie7; Willems, Bernard8; Vargas, Hugo9; Kumar, Princy10; Brown-Junior, Robert S11; Horsmans, Yves12; De Oertel, Shampa13; Arterburn, Sarah13; Dvory Sobol, Hadas13; Brainard, Diana M13; McHutchison, John G13; Terrault, Norah14; Rizzetto, Mario15; Mullhaupt, Beat16
1Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá; 2Indiana University, School of Medicine, Indianapolis, Indiana. Estados Unidos de América; 3King’s College Hospital Foundation Trust, Institute of Liver Studies, Londres. Reino Unido; 4Universite Paris-Est Creteil, Centre Hospitalier Universitaire Henri-Mondor, Val de Marne, París. Francia; 5Universite Paris Diderot, Beaujon Hospital, Clichy, París. Francia; 6Medical University of Vienna, Department of Gastroenterology and Hepatology, Viena. Austria; 7University of Toronto, Toronto General Hospital, Toronto, Ontario. Canadá; 8Universite de Montreal, Hospital Saint Luc, Montreal, Quebec. Canadá; 9Mayo Clinic, Division of Gastroenterology and Hepatology, Phoenix, Arizona. Estados Unidos de América; 10Georgetown University, Division of Infectious Diseases, Washington, Distrito de Columbia. Estados Unidos de América; 11Weill Cornell Medical College, Division of Gastroenterology and Hepatology, Nueva York. Estados Unidos de América; 12Universite Catholique de Louvain, Lovaina. Bélgica; 13Gilead Sciences, Inc., Foster City, California. Estados Unidos de América; 14University of California, Division of Gastroenterology and Hepatology, San Francisco, California. Estados Unidos de América; 15Universita di Torino, Dipartimento di Gastroenterologia, Turín, Piemonte. Italia; 16University Hospital Zurich, Department for Gastroenterology and Hepatology, Zurich. Suiza
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 375-381]

   
12.-
13.-
14.-
Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report
Li, Hui1; Ma, Zhi1; Xie, Ying1; Tian, Feng1
1China Medical University, Shengjing Hospital, Shenyang, Liaoning. China
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 460-464]

   
15.-
16.-
17.-
Spontaneous Resolution of Multiple Hepatic Masses: Hepatic Inflammatory Pseuduotumor
Qi, Xingshun1; Han, Lei2; Arora, Ankur3; Hou, Yue1; Wang, Ran1; Chang, Sha1; Guo, Xiaozhong1
1General Hospital of Shenyang, Department of Gastroenterology, Shenyang, Liaoning. China; 2General Hospital of Shenyang, Department of Hepatobiliary Surgery, Shenyang, Liaoning. China; 3Worthing Hospital, Department of Radiology, Worthing, West Sussex. Reino Unido
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 457-459]

   
18.-
19.-
20.-
The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
Chinchilla López, Paulina1; Qi, Xingshun2; Yoshida, Eric M3; Méndez Sánchez, Nahum1
1Fundación Clínica Médica Sur, Unidad de Investigación de Hígado, Ciudad de México. México; 2General Hospital of Shenyang Military Area, Department of Gastroenterology, Shenyang, Liaoning. China; 3Vancouver General Hospital, Division of Gastroenterology, Vancouver, Columbia Británica. Canadá
[Annals of hepatology, México, 2017 Vol. 16 Núm. 3 May-Jun, Pág. 328-330]